0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HK$
0,00%
(0,00) 1D
16 қаз., 16:08:14 GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
0,51 HK$
High
0,52 HK$
Low
0,51 HK$
Mkt. cap
4,90 млрд
Avg. vol.
1,66 млн
Volume
956,00 м.
52-wk high
1,02 HK$
52-wk low
0,51 HK$
EPS
-0,01 HK$
Shares outstanding
9,61 млрд
No. of employees
2 мың
Open
0,51 HK$
High
0,52 HK$
Low
0,51 HK$
Mkt. cap
4,90 млрд
Avg. vol.
1,66 млн
Volume
956,00 м.
52-wk high
1,02 HK$
52-wk low
0,51 HK$
EPS
-0,01 HK$
Shares outstanding
9,61 млрд
No. of employees
2 мың
News stories
From web sources and news partners
Capital Brief
·
8 минут бұрын
Australian shares to open lower as chip selloff weighs on Nasdaq
Yahoo Finance
·
12 сағат бұрын
Michael Burry Warns of a Stock Market ‘Supervolcano’
AOL.com
·
8 сағат бұрын
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
MarketWatch
·
7 сағат бұрын
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc